Characterization of the Adjuvant Effect of IL‐12 and Efficacy of IL‐12 Inhibitors in Type II Collagen‐Induced Arthritisa
1996; Wiley; Volume: 795; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1996.tb52672.x
ISSN1749-6632
AutoresTieno Germann, Henry Hess, Jacek Szeliga, Erwin Rüde,
Tópico(s)Immunotherapy and Immune Responses
ResumoAnnals of the New York Academy of SciencesVolume 795, Issue 1 p. 227-240 Characterization of the Adjuvant Effect of IL-12 and Efficacy of IL-12 Inhibitors in Type II Collagen-Induced Arthritisa TIENO GERMANN, TIENO GERMANN Universität Mainz, Institut für Immunologic, Obere Zahlbacher Straβe 67, 55101 Mainz, GermanySearch for more papers by this authorHENRY HESS, HENRY HESS Universität Mainz, Institut für Immunologic, Obere Zahlbacher Straβe 67, 55101 Mainz, GermanySearch for more papers by this authorJACEK SZELIGA, JACEK SZELIGA Universität Mainz, Institut für Immunologic, Obere Zahlbacher Straβe 67, 55101 Mainz, GermanySearch for more papers by this authorERWIN RÜDE, ERWIN RÜDE Universität Mainz, Institut für Immunologic, Obere Zahlbacher Straβe 67, 55101 Mainz, GermanySearch for more papers by this author TIENO GERMANN, TIENO GERMANN Universität Mainz, Institut für Immunologic, Obere Zahlbacher Straβe 67, 55101 Mainz, GermanySearch for more papers by this authorHENRY HESS, HENRY HESS Universität Mainz, Institut für Immunologic, Obere Zahlbacher Straβe 67, 55101 Mainz, GermanySearch for more papers by this authorJACEK SZELIGA, JACEK SZELIGA Universität Mainz, Institut für Immunologic, Obere Zahlbacher Straβe 67, 55101 Mainz, GermanySearch for more papers by this authorERWIN RÜDE, ERWIN RÜDE Universität Mainz, Institut für Immunologic, Obere Zahlbacher Straβe 67, 55101 Mainz, GermanySearch for more papers by this author First published: October 1996 https://doi.org/10.1111/j.1749-6632.1996.tb52672.xCitations: 28 a This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungs-bereich 311, and a DFG grant to Jacek Szeliga. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Courtenay, J. S., M. J. Dallman, A. D. Dayan, A. Martin & B. Mosedale. 1980. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283: 666– 668. 2 Wooley, P. H., H. S. Luthra, J. M. Stuart & C. S. David. 1981. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (1 region) linkage and antibody correlates. J. Exp, Med. 154: 688– 700. 3 Stuart, J. M., A. S. Townes & A. H. Kang. 1984. Collagen autoimmune arthritis. Annu. Rev. Immunol. 2: 199– 218. 4 Trentham, D. E. 1982. Collagen arthritis as a relevant model for rheumatoid arthritis. Arthritis Rheum. 25: 911. 5 Ranges, G. E., S. Sriram & S. M. Cooper. 1985. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J. Exp. Med. 162: 1105– 1110. 6 Holmdahl, R., L. Klareskog, K. Rubin, E. Larsson & H. Wigzell. 1985. T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen 11-specific T-cell lines and clones. Scand. J. Immunol. 22: 295– 306. 7 Seki, N., Y. Sudo, T. Yoshioka, S. Sugihara, T. Fujitsu, S. Sakuma, T. Ogawa, T. Hamaoka, H. Senoh & H. Fujiwara. 1988. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J. Immunol. 140: 1477– 1484. 8 Kadowaki, K. M., H. Matsuno, H. Tsuji & I. Tunru. 1994. CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clin. Exp. Immunol. 97: 212– 218. 9 Taylor, P. C., C. Plater-Zyberk & R. N. Maini. 1995. The role of the B cells in the adoptive transfer of collagen-induced arthritis from DBA/1 (H-2q) to SCID (H-2d) mice. Eur. J. Immunol. 25: 763– 769. 10 Jansson, L. & R. Holmdahl. 1993. Genes on the X chromosome affect development of collagen-induced arthritis in mice. Clin. Exp. Immunol. 94: 459– 465. 11 Durie, F. H., R. A. Fava, T. M. Foy, A. Aruffo, J. A. Ledbetter & R. J. Noelle. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261: 1328– 1330. 12 Watson, W. C. & A. S. Townes. 1985. Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J. Exp. Med. 162: 1878– 1891. 13 Stuart, J. M. & F. J. Dixon. 1983. Serum transfer of collagen-induced arthritis in mice. J. Exp. Med. 158: 378– 392. 14 Myers, L. K., E. F. Rosloniec, J. M. Seyer, J. M. Stuart & A. H. Kang. 1993. A synthetic peptide analogue of a determinant of type II collagen prevents the onset of collagen-induced arthritis. J. Immunol. 150: 4652– 4658. 15 Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin & R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348– 2357. 16 Bottomly, K. 1988. A functional dichotomy in CD4+ T lymphocytes [see commentsl. Immunol. Today 9: 268– 274. 17 Finkelman, F. D., J. Holmes, I. M. Katona, J. F. J. Urban, M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann & W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8: 303– 333. 18 HayGlass, K. T. & B. P. Stefura. 1991. Anti-interferon gamma treatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses. J. Exp. Med. 173: 279– 285. 19 DeKruyff, R. H., S. T. Ju, A. J. Hunt, T. R. Mosmann & D. T. Umetsu. 1989. Induction of antigen-specific antibody responses in primed and unprimed B cells. Functional heterogeneity among Thl and Th2 T cell clones. J. Immunol. 142: 2575– 2582. 20 Snapper, C. M. & W. E. Paul. 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944– 947. 21 Liblau, R. S., S. M. Singer & H. O. McDevitt. 1995. Thl and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16: 34– 38. 22 Rapoport, M. J., A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Serreze, E. H. Leiter, P. Cyopick, J. S. Danska & T. L. Delovitch. 1993. Interleukin 4 reverses T-cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178: 87– 99. 23 Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach & M. Röcken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180: 1961– 1966. 24 Allen, J. B., G. P. Bansal, G. M. Feldman, A. O. Hand, L. M. Wahl & S. M. Wahl. 1991. Suppression of bacterial cell wall-induced polyarthritis by recombinant gamma interferon. Cytokine 3: 98– 106. 25 Cooper, S. M., S. Sriram & G. E. Ranges. 1988. Suppression of murine collagen-induced arthritis with monoclonal anit-Ia antibodies and augmentation with IFN-gamma. J. Immunol. 141: 1958– 1962. 26 Mauritz, N. J., R. Holmdahl, R. Jonsson, P. H. Van der Meide, A. Scheynius & L. Klareskog. 1988. Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum. 31: 1297– 1304. 27 Swain, S. L., A. D. Weinberg, M. English & G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145: 3796– 3806. 28 Seder, R. A., W. E. Paul, M. M. Davis & de St. B. Fazekas Groth. 1992. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T-cell receptor transgenic mice. J. Exp. Med. 176: 1091– 1098. 29 Trinchieri, G. 1994. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84: 4008– 4027. 30 Germann, T. & E. Rüde. 1995. Interleukin-12. Int. Arch. Allergy Immunol. 108: 103– 112. 31 Hsieh, C. S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra & K. M. Murphy. 1993. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages [see comments]. Science 260: 547– 549. 32 Schmitt, E., P. Hoehn, C. Huels, S. Goedert, N. Palm, E. Rude & T. Germann. 1994. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. Eur. J. Immunol. 24: 793– 798. 33 Germann, T., J. Szeliga, H. Hess, S. Störkel, F. J. Podlaski, M. K. Gately, E. Schmitt & E. Rüde. 1995. Administration of interleukin-12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA 92: 4823– 4827. 34 Gately, M. K., R. R. Warrier, S. Honasoge, D. M. Carvajal, D. A. Faherty, S. E. Connaughton, T. D. Anderson, U. Sarmiento, B. R. Hubbard & M. Murphy. 1994. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γin vivo. Int. Immunol. 6: 157– 167. 35 Cherwinski, H. M., J. H. Schumacher, K. D. Brown & T. R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Thl and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166: 1229– 1244. 36 Germann, T., M. Bongartz, H. Dlugonska, H. Hess, E. Schmitt, L. Kolbe, E. Kölsch, F. J. Podlaski, M. K. Gately & E. Rüde. 1995. IL-12 profoundly upregulates the synthesis of antigen-specific, complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25: 823– 829. 37 Schijns, V. E., B. L. Haagmans, E. O. Rijke, S. Huang, M. Aguet & M. C. Horzinek. 1994. IFN-γ receptor-deficient mice generate antiviral Thl-characteristic cytokine profiles but altered antibody responses. J. Immunol. 153: 2029– 2037. 38 Swihart, K., U. Fruth, N. Messmer, K. Hug, R. Behin, S. Huang, G. Del Oiudice, M. Aguet & J. A. Louis. 1995. Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response. J. Exp. Med. 181: 961– 971. 39 Wynn, T. A., D. Jankovic, S. Hieny, K. Zioncheck, P. Jardieu, A. W. Cheever & A. Sher. 1995. IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-γ. J. Immunol. 154: 3999– 4009. 40 Hsieh, C. S., S. E. Macatonia, A. O'Garra & K. M. Murphy. 1993. Pathogen-induced Thl phenotype development in CD4+ alpha beta-TCR transgenic T cells is macrophage dependent. Int. Immunol. 5: 371– 382. 41 Wu, C. Y., C. Demeure, M. Kiniwa, M. Gately & G. Delespesse. 1993. IL-12 induces the production of IL-12 by neonatal human CD4 T cells. J. Immunol. 151: 1938– 1949. 42 Gajewski, T. F. & F. W. Fitch. 1988. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Thl murine helper T lymphocyte clones. J. Immunol. 140: 4245– 4252. 43 Parronchi, P., M. De Carli, R. Manetti, C. Simonelli, S. Sampognaro, M. P. Piccinni, D. Macchia, E. Maggi, G. Del Prete & S. Romagnani. 1992. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th 1 or Th2 human T cell clones. J. Immunol. 149: 2977– 2983. 44 Murray, J. S., J. Madri, T. Pasqualini & K. Bottomly. 1993. Functional CD4 T cell subset interplay in an intact immune system. J. Immunol. 150: 4270– 4276. 45 Scott, P. 1991. IFN-γ modulates the early development of Thl and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147: 3149– 3155. 46 Jelinek, D. F. & J. K. Braaten. 1995. Role of IL-12 in human B lymphocyte proliferation and differentiation. J. Immunol. 154: 1606– 1613. 47 Finkelman, F. D., I. M. Katona, T. R. Mosmann & R. L. Coffman. 1988. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140: 1022– 1027. 48 Buchanan, J. M., L. A. Vogel, V. H. Van Cleave & D. W. Metzger. 1995. Interleukin 12 alters the isotype-restricted antibody response of mice to hen eggwhite lysozyme. Int. Immunol. 7: 1519– 1528. 49 Kiniwa, M., M. Gately, U. Gubler, R. Chizzonite, C. Fargeas & G. Delespesse. 1992. Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J. Clin. Invest. 90: 262– 266. 50 Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Gause, B. R. Hubbard, M. K. Gately & F. D. Finkelman. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152: 1047– 1056. 51 McKnight, A. J., G. J. Zimmer, I. Fogelman, S. F. Wolf & A. K. Abbas. 1994. Effects of IL-12 on helperT cell-dependent immune responses in vivo. J. Immunol. 152: 2172– 2179. 52 Milich, D. R., S. F. Wolf, J. L. Hughes & J. E. Jones. 1995. Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice. Proc. Natl. Acad. Sci. USA 92: 6847– 6851. 53 Leonard, J. P., K. E. Waldburger & S. J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181: 381– 386. 54 Trembleau, S., G. Penna, E. Bosi, A. Mortara, M. K. Gately & L. Adorini. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in nod mice. J. Exp. Med. 181: 817– 821. 55 Ogata, L. C., C. Reilly, L. A. M. Marconi & D. Lo. 1995. Anti-1L-12 antibody can prevent autoimmune diabetes in an adoptive transfer murine model. J. Cell. Biochem. Suppl. 21A(C2-463): 150. 56 Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stüber & W. Strober. 1995. Antibodies to IL-12 abrogate established granulomatous colitis in mice. J. Exp. Med. 182: 1281– 1290. Citing Literature Volume795, Issue1Interleukin 12: Cellular and Molecular Immunology of an Important Regulatory CytokineOctober 1996Pages 227-240 ReferencesRelatedInformation
Referência(s)